Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MA

Ikeda, Shuhei; Sugiyama, Hideyuki; Tokuhara, Hidekazu; Murakami, Masataka; Nakamura, Minoru; Oguro, Yuya; Aida, Jumpei; Morishita, Nao; Sogabe, Satoshi; Dougan, Douglas R.; Gay, Sean C.; Qin, Ling; Arimura, Naoto; Takahashi, Yasuko; Sasaki, Masako; Kamada, Yusuke; Aoyama, Kazunobu; Kimoto, Kouya; Kamata, Makoto

doi:10.1021/acs.jmedchem.1c00432

Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MA

Journal Article · 01 July 2021 · J. Med. Chem.

DOI:https://doi.org/10.1021/acs.jmedchem.1c00432· OSTI ID:1834911

Ikeda, Shuhei; Sugiyama, Hideyuki; Tokuhara, Hidekazu; Murakami, Masataka; Nakamura, Minoru; Oguro, Yuya; Aida, Jumpei; Morishita, Nao; Sogabe, Satoshi; Dougan, Douglas R.; Gay, Sean C.; Qin, Ling; Arimura, Naoto; Takahashi, Yasuko; Sasaki, Masako; Kamada, Yusuke; Aoyama, Kazunobu; Kimoto, Kouya; Kamata, Makoto

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; INDUSTRY

OSTI ID:: 1834911

Journal Information:: J. Med. Chem., Vol. 64, Issue (15)

Country of Publication:: United States

Language:: ENGLISH

References (42)

Endocannabinoid-Mediated Control of Synaptic Transmission No authors listed Physiological Reviews https://doi.org/10.1152/physrev.00019.2008		January 2009
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain No authors listed Biochemical and Biophysical Research Communications https://doi.org/10.1006/bbrc.1995.2437		October 1995
Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor No authors listed Journal of Biological Chemistry https://doi.org/10.1074/jbc.274.5.2794		January 1999
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand No authors listed Progress in Lipid Research https://doi.org/10.1016/j.plipres.2006.03.003		September 2006
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol No authors listed Chemistry & Biology https://doi.org/10.1016/j.chembiol.2007.11.006		December 2007
The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors: The three guardians of 2-AG signalling No authors listed Acta Physiologica https://doi.org/10.1111/j.1748-1716.2011.02280.x		April 2011
The pharmacological landscape and therapeutic potential of serine hydrolases No authors listed Nature Reviews Drug Discovery https://doi.org/10.1038/nrd3620		January 2012
cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase No authors listed Journal of Biological Chemistry https://doi.org/10.1074/jbc.272.43.27218		October 1997
A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation No authors listed Chemistry and Physics of Lipids https://doi.org/10.1016/S0009-3084(02)00150-0		December 2002
Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism No authors listed Chemistry & Biology https://doi.org/10.1016/j.chembiol.2009.05.009		July 2009
Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation No authors listed Science https://doi.org/10.1126/science.1209200		November 2011
Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N -Acylethanolamine Acid Amidase Inhibitors No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.6b00538		November 2016
An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present) No authors listed Expert Opinion on Therapeutic Patents https://doi.org/10.1080/13543776.2021.1841166		November 2020
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017) No authors listed Expert Opinion on Therapeutic Patents https://doi.org/10.1080/13543776.2018.1389899		September 2017
Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids No authors listed Chem. Soc. Rev. https://doi.org/10.1039/C4CS00047A		January 2014
Chemical Probes of Endocannabinoid Metabolism No authors listed Pharmacological Reviews https://doi.org/10.1124/pr.112.006387		February 2013
Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling No authors listed Pharmacology & Therapeutics https://doi.org/10.1016/j.pharmthera.2017.02.033		July 2017
Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures No authors listed Cell Reports https://doi.org/10.1016/j.celrep.2016.06.083		August 2016
Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.8b00951		August 2018
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.8b00070		March 2018
Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.7b01531		December 2017
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system No authors listed Nature Neuroscience https://doi.org/10.1038/nn.2616		August 2010
Design, Synthesis, and Evaluation of Piperazinyl Pyrrolidin-2-ones as a Novel Series of Reversible Monoacylglycerol Lipase Inhibitors No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.8b00824		September 2018
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.8b01483		February 2019
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.7b01845		January 2018
Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.6b01459		November 2016
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis No authors listed Angewandte Chemie International Edition https://doi.org/10.1002/anie.201407807		October 2014
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor No authors listed Journal of Pharmacology and Experimental Therapeutics https://doi.org/10.1124/jpet.119.262139		December 2019
The discovery of diazetidinyl diamides as potent and reversible inhibitors of monoacylglycerol lipase (MAGL) No authors listed Bioorganic & Medicinal Chemistry Letters https://doi.org/10.1016/j.bmcl.2020.127198		June 2020
The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitors No authors listed Bioorganic & Medicinal Chemistry Letters https://doi.org/10.1016/j.bmcl.2020.127243		July 2020
Discovery of Potent and Reversible Monoacylglycerol Lipase Inhibitors No authors listed Chemistry & Biology https://doi.org/10.1016/j.chembiol.2009.09.012		October 2009
The influence of drug-like concepts on decision-making in medicinal chemistry No authors listed Nature Reviews Drug Discovery https://doi.org/10.1038/nrd2445		November 2007
Kinetic solubility and lipophilicity evaluation connecting formulation technology strategy perspective No authors listed Journal of Drug Delivery Science and Technology https://doi.org/10.1016/j.jddst.2016.03.002		June 2016
Structural Basis for Human Monoglyceride Lipase Inhibition No authors listed Journal of Molecular Biology https://doi.org/10.1016/j.jmb.2009.11.060		February 2010
Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution: Crystal Structure of Monoglyceride Lipase No authors listed Protein Science https://doi.org/10.1002/pro.596		March 2011
A Medicinal Chemist’s Guide to Molecular Interactions No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/jm100112j		July 2010
CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/jm501535r		January 2015
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/jm901241e		November 2009
Impact of Physicochemical Profiling for Rational Approach on Drug Discovery No authors listed Chemical and Pharmaceutical Bulletin https://doi.org/10.1248/cpb.c13-00436		January 2013
Design, synthesis, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors No authors listed Bioorganic & Medicinal Chemistry https://doi.org/10.1016/j.bmc.2013.12.023		February 2014
The design of efficient and selective routes to pyridyl analogues of 3-oxo-3,4-dihydro-2H-1,4-(benzothiazine or benzoxazine)-6-carbaldehydes No authors listed Tetrahedron Letters https://doi.org/10.1016/j.tetlet.2010.07.095		September 2010
Establishment and Characterization of the Transformants Stably-Expressing MDR1 Derived from Various Animal Species in LLC-PK1 No authors listed Pharmaceutical Research https://doi.org/10.1007/s11095-006-0285-7		June 2006

Similar Records

Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MA

Journal Article · 2021 · J. Med. Chem. · OSTI ID:1832571

Ikeda, Shuhei; Sugiyama, Hideyuki; Tokuhara, Hidekazu; +16 more

Synthesis and characterization of novel spiro penta- and hexacoordinate anionic polysiliconate and polygermylate ionomers derived from the condensation of ({plus_minus}) 5,5{prime}, 6,6{prime} - Tetrahydroxy-1,1{prime} - spiro-bis(Indane) with trialkoxysilanes, tetraalkoxysilanes, and trialkoxygermanes

Conference · 1993 · OSTI ID:10106488

Small, J H; Shea, K J; Loy, D A; +1 more

A probe for octopamine receptors: Synthesis of 2-((4-azido-2,6-diethylphenyl)imino)imidazolidine and its tritiated derivative, a potent reversible-irreversible activator of octopamine-sensitive adenylate cyclase

Journal Article · 1989 · Journal of Medicinal Chemistry; (USA) · OSTI ID:5478917

Nathanson, J A; Kaugars, G

Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MA

Citation Formats

References (42)

Similar Records

Related Subjects